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ABSTRACT: Credneramides A (1) and B (2), two vinyl
chloride-containing metabolites, were isolated from a Papua
New Guinea collection of cf. Trichodesmium sp. nov. and
expand a recently described class of vinyl chloride-containing
natural products. The precursor fatty acid, credneric acid (3),
was isolated from both the aqueous and organic fractions of
the parent fraction as well as from another geographically and
phylogenetically distinct cyanobacterial collection (Panama).
Credneramides A and B inhibited spontaneous calcium
oscillations in murine cerebrocortical neurons at low micro-
molar concentrations (1, IC50 4.0 μM; 2, IC50 3.8 μM).
I t has been exceptionally productive to search for structurallynovel and biologically active natural products in marine
cyanobacteria, especially among filamentous types.1,2 For
example, the vinyl chloride-containing jamaicamides A−C and
the structurally diverse malyngamides A−X have been found
from marine cyanobacteria or opisthobranch mollusks that feed
on these photosynthetic prokaryotes.1,3 However, it is
important to note that field-collected cyanobacteria are rich
substrates for heterotrophic bacterial growth,4 and thus it is
conceivable that the latter organisms are the source for some of
these natural products.5 In a few cases, a microbial symbiont
has been shown rigorously to be the actual producer of a
compound obtained from a macroorganism.6−8 For example,
the biosynthetic machinery of the bacterial symbiont
Endobugula sertula has been shown to produce the anticancer
bryostatin natural products that were first reported from the
host bryozoan Bugula neritina.7 Similarly, the unicellular
symbiotic cyanobacterium Prochloron sp. has been shown to
be the biosynthetic source of the patellamides, originally
reported from the host tunicate Lissoclinum patella.8 Thus, in
many cases the metabolic origin of marine secondary
metabolites remains largely speculative at present.6
Interestingly, the jamaicamides and malynamides have a
common biosynthetic theme in that they possess a PKS-derived
long lipid chain and a NRPS-derived peptidic moiety.9
Furthermore, all three jamaicamides and 22 of the 29 reported
malyngamides contain the unusual and highly distinctive vinyl
chloride functional group.1,3 Because the vinyl chloride unit is
predicted to reside on C-1 of the glycine-derived unit, the sp2
carbon bearing the chloride is predicted to derive from the C-2
carbon of a pendant acetate unit.10 Likewise, in the
jamaicamides,11 the vinyl chloride carbon has been shown to
be derived from C-2 of acetate via a complex biosynthetic
process involving an HMGCoA synthase catalytic unit and to
be highly similar to that responsible for cyclopropyl ring
formation in curacin A.3,12
Among cyanobacterial natural products, particularly Lyngbya
majuscula, the phenethylamine moiety has been reported in
several natural products, including grenadamide (lyngbyamide
A), hermitamide A, and lyngbyamide B, which harbors a p-
hydroxy group on the phenethylamine group.13−15 Phenethyl-
amines (PEA) are well known for their psychotropic effects and
have been isolated from a variety of organisms, including
octocorals, the edible mushroom Laetiporus sulphureus,
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Streptomyces sp., Enterococcus sp., and other species of
cyanobacteria.16−20 In accordance with the neurotropic activity
of PEAs, grenadamide exhibits cannabinoid receptor binding
activity (Ki 4.7 μM)
13 and brine shrimp toxicity (LD50 5 μg/
mL), whereas hermitamide A is cytotoxic to neuro-2A murine
neuroblastoma cells (IC50 2.2 μM) and brine shrimp (LD50 5
μM).13,14 Lyngbyamide B was reported to be cytotoxic to brine
shrimp (LD50 6.5 ppm).
15 For each of the cyanobacterial
compounds containing a phenethylamine moiety, the “pre-
cursor” fatty acid was also isolated along with the elaborated
natural product.13,14 As seen with the malyngamides, the
precursor fatty acid is a chemical scaffold to which the
cyanobacterium adds further functional groups, and this
appears to enhance their biological activity.21 This theme of
chemical scaffolding to functionalize and enhance bioactivity is
also observed with the credneramides. Herein, we report the
isolation and structure elucidation of credneramides A (1) and
B (2) and credneric acid (3), neuromodulatory cyanobacterial
compounds isolated from a Papua New Guinea collection of cf.
Trichodesmium sp. nov. Additionally, credneric acid (3) was also
isolated from a strain of cf. Oscillatoria sp. obtained from the
Eastern Pacific (Panama). Because credneric acid was also
reported recently from a field collection of the bacterium
Rhodopirellula baltica,22 several interesting questions emerge as
to the origin of this compound class, the phylogenetic
relationships of the producing organisms, and the evolutionary
history of the putative biosynthetic pathway.
■ RESULTS AND DISCUSSION
Natural Product Isolation and Structure Elucidation.
Credneramides A (1) and B (2) were isolated from the organic
extract of the cyanobacterium cf. Trichodesmium sp. nov.
collected near the Credner Islands, Papua New Guinea. Using
silica gel vacuum-liquid chromatography, the extract was
fractionated into nine subfractions (A−I) of increasing polarity,
and fraction E was further purified using reversed-phase HPLC.
The HRESIMS data ([M + H]+ m/z 320.1779) of
credneramide A (1) established the molecular formula as
C19H26ClNO with seven degrees of unsaturation; the presence
of one chlorine atom was supported by the isotopic pattern.
The 1H NMR spectrum was well dispersed and contained two
distinctive resonances similar to that of the malyngamide series
and diagnostic of a vinyl chloride functionality and a
disubstituted olefin. In particular, these resonances were a
sharp singlet at 5.77 ppm (δC 113.1 ppm) and two narrowly
resolved multiplets at 5.37 and 5.45 ppm (δC 127.8, 131.2,
respectively; Table 1). Three resonances in the aromatic region
of the 1H NMR spectrum (δH 7.19, δC 128.7; δH 7.24, δC 126.5;
δH 7.32, δC 128.7) were suggestive of the presence of a
monosubstituted phenyl group, and a carbon resonance at
172.1 ppm indicated the presence of an ester or amide
carbonyl.
A combination of 2D COSY, HSQC, and HMBC
correlations was used subsequently to complete the planar
structure of credneramide A (1) (Figure 1). COSY correlations
were used to assign consecutively two methylenes (δ 1.43 and
2.15) adjacent to the terminal methyl at C-10 as well as to
relate the C-3 and C-6 methylenes (δH 2.32 and 2.70) with
each methine (δH 5.37 and 5.45) of the C-4/C-5 olefin. A
HMBC correlation between H-2 and C-3 permitted connection
of the C-2/C-3 methylenes, and a correlation between H-2 and
C-1 allowed placement of the ester/amide carbonyl group
adjacent to the C-2 methylene. Additional HMBC correlations
between H-6 and C-11/C-7 permitted attachment of the vinyl
chloride to this carbon chain. Integrated 1H NMR and COSY
data supported the presence of a phenethyl moiety with five
aromatic protons and coupling of the C-1′/C-2′ methylenes at
3.53 and 2.81 ppm, respectively (Figure 1). The complement of
Table 1. 1H and 13C NMR Data for Credneramide A (1) and
Credneramide B (2)
credneramide A (1) credneramide B (2)
carbon
δC,
mult.a
δH, mult. (J
in Hz)b HMBCb
δC,
mult.c
δH, mult. (J
in Hz)d HMBCd
1 172.1,
qC
172.1,
qC
2 36.4,
CH2
2.19, t (7.0) 1, 3, 4 36.4,
CH2
2.22, t (6.9) 1, 3, 4
3 28.4,
CH2
2.32, dt
(7.0, 6.6)
1, 2, 4, 5 28.5,
CH2
2.35, dt
(6.9, 6.1)
1, 2, 4, 5
4 131.2,
CH
5.43, dt
(15.3,
6.6)
2, 5, 6 131.3,
CH
5.48, dt
(14.9,
6.1)
2, 3, 5, 6
5 127.8,
CH
5.47, dt
(15.3,
6.7)
3, 4 127.8,
CH
5.41, dt
(14.9,
6.1)
3, 4, 6, 7
6 37.9,
CH2
2.70, d
(6.7)
4, 5, 7, 8,
11
37.9,
CH2
2.72, d
(6.1)
4, 5, 7, 8,
11
7 141.5,
qC
141.5,
qC
8 32.3,
CH2
2.15, t (6.7) 6, 7, 9,
10, 11
32.2,
CH2
2.15, t (7.6) 6, 7, 9,
10, 11
9 20.2,
CH2
1.43 h (7.5) 7, 8, 10 20.2,
CH2
1.43, h
(7.6)
7, 8, 10
10 13.9,
CH3
0.91 t (7.5) 8, 9 13.9,
CH3
0.91, m 8, 9
11 113.1,
CH
5.77, s 6, 7, 8 113.1,
CH
5.78, s 6, 7, 8, 9
NH 5.42 d (6.2) 5.39
1′ 40.5,
CH2
3.53 (dt
(6.9, 6.2)
1, 2′, 3′ 37.8,
CH2
3.26, dt
(7.2, 6.5)
1, 2′, 3′
2′ 35.7,
CH2
2.81, t (6.9) 1′, 3′, 4′ 38.5,
CH2
1.36, dt
(7.5, 7.2)
1′, 3′, 4′,
5′
3′ 138.9,
qC
25.9,
CH
1.60, m 2′, 4′, 5′
4′ 128.7,
CH
7.19, d
(7.2)
2′, 5′, 6′,
7′
22.4,
CH3
0.90, m 3′, 5′
5′ 128.7,
CH
7.32, dd
(7.2)
3′, 4′ 22.4,
CH3
0.90, m 3′, 4′
6′ 128.5,
CH
7.24, t (7.2) 4′
7′ 128.7,
CH
7.32, t (7.2) 3′, 4′
8′ 128.7,
CH
7.19, d
(7.2)
2′, 5′, 6′,
7′
a75 MHz in CDCl3.
b500 MHz in CDCl3.
c150 MHz in CDCl3.
d600
MHz in CDCl3.
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1H NMR and 13C NMR chemical shifts for H-1′/C-1′ (δH 3.53;
δC 40.5) supported its direct attachment to a nitrogen atom.
HMBC correlations between H-1′ and C-2′/C-3′ and multiple
correlations between the protons and carbons of the aromatic
ring confirmed the presence of a phenethylamine moiety
(Table 1). Lastly, a key HMBC correlation between H-1′ and
C-1 permitted connection of the phenethylamine through an
amide linkage to the vinyl chloride-containing fatty acid
portion, thus completing the planar structure of credneramide
A (1).
Assignment of the geometry of the two olefins in 1 was
accomplished by 1D NOE, 2D ROE, and homonuclear
coupling constants. A key NOE/ROE correlation between
the vinyl proton and the H-6 methylene established the C-7
olefin as E. A 3JH−H 15.3 Hz coupling constant between the
vinyl protons at H-4 and H-5 permitted assignment of the C-4
olefin as E as well.
The second credneramide metabolite, credneramide B (2),
was isolated in only about 60% of the yield of credneramide A
(1) and showed by HRESIMS a [M + H]+ peak at m/z
286.1963 for a molecular formula of C16H28ClNO. A
comparison of the 1H and 13C NMR chemical shifts of 1 and
2 revealed their close similarity with the notable absence of
aromatic absorptions in the spectra for 2. Moreover, the 1H
Figure 1. Key COSY, HMBC, and ROE correlations of credneramides
A (1) and B (2).
Figure 2. Evolutionary tree of the credneramide-producing strain PNG-05/19/05-13. The phylogenetic proximity with the genus Trichodesmium
(reference/type-strains = Trichodesmium erythraeum IMS) suggests that this strain represents a new taxa within this genus, which would also include
the related and morphologically similar strains PAL08-3.2 (GenBank acc. no. HM585025) and NAC8-50 (GenBank acc. no. GU724203) previously
putatively identified as cf. Oscillatoria sp. Representative reference-strains obtained from Bergey’s Manual are highlighted with asterisks (*), and the
sensu stricto for the genera Trichodesmium and Oscillatoria are highlighted with green boxes. In addition to the strain PNG-05/19/05-13, credneric
acid (3) was also isolated from the Panamanian strain cf. Oscillatoria sp. PAC-17-FEB-10-3 (both credneric acid-producing strains are highlighted
with red arrows). The cladogram is based on SSU (16S) rRNA gene sequences using the Bayesian (MrBayes) method, and the support values are
indicated as posterior probability at the nodes. The specimens are indicated as species, strain, and access number in parentheses. The scale bar is
indicated at 0.04 expected nucleotide substitutions per site.
Journal of Natural Products Article
dx.doi.org/10.1021/np200611f | J. Nat. Prod. 2012, 75, 60−6662
NMR of compound 2 lacked the distinctive triplet at δ 2.81
present in the spectrum of 1, and this was replaced with an
additional methylene triplet at δ 1.36 and a methine multiplet
at δ 1.60. Analysis of gHSQC data indicated the presence of
two additional terminal methyl groups in the higher field
region. COSY correlations defined the adjacent positions of the
doublet of triplets at δ 1.36 to the C-1′ methylene at δ 3.26 and
to the C-3′ methine at δ 1.60. A HMBC correlation (δH = 0.90
ppm, δC = 22.4 ppm) suggested a terminal gem-dimethyl
grouping, and a correlation between the C-3′ methine and the
two terminal methyls allowed the assignment of an isopentyl-
amine moiety. Finally, a key HMBC correlation between the C-
1′ methylene and the carbonyl (δC 172.0) permitted attachment
of the isopentylamine to the rest of the molecule to complete
the planar structure of 2. In similar fashion to credneramide A
(1), a key NOE correlation between the vinyl proton and the
H-6 methylene established the C-7 olefin as having an E
geometry in credneramide B (2), and a 3JHH 14.9 Hz coupling
constant between the vinyl protons permitted assignment of
the C-4 olefin as also being E.
The precursor vinyl chloride fatty acid, credneric acid (3),
was isolated from both the aqueous and organic portions of the
same parent extract. The initial analysis of 3 was done by 1H
NMR spectroscopy, which revealed that it was a short fatty
acid. Analysis by COSY and HSQC revealed the presence of an
n-propyl group. Further analysis by the same methods revealed
another spin system consisting of two consecutive methylene
groups, a disubstituted olefin, and another methylene group. A
trisubstituted vinyl chloride functionality was postulated on the
basis of the two- and three-bond heteronuclear coupling
information obtained by HMBC analysis. Finally, HMBC
analysis also allowed connection of the three substructures to
form the fatty acid portion of credneramides A and B. Again,
the stereochemical assignment of the two olefins in 3 were
made by the coupling constant between the two vicinal vinyl
protons (5.42 and 5.48 ppm; J = 15.4 Hz) and 1D ROESY
correlations of key protons on and around the olefins, and these
were in accordance with those of compounds 1 and 2.21
Credneramides A (1) and B (2), along with the recently
reported grenadamides B and C, constitute a new class of vinyl
chloride-containing fatty acids in cyanobacteria.23 A common-
ality shared among the credneramides is an apparent reductive
decarboxylation of the amide head group. Reductive decarbox-
ylation of phenylalanine (Phe) is expected to proceed via a
phenylalanine decarboxylase or a tyrosine (Tyr) decarboxylase
with promiscuity toward the related Phe residue.20 Similarly,
the isopentylamine functionality is predicted to arise from
reductive decarboxylation of leucine by a putative leucine
decarboxylase. Vinyl chloride formation in the credneramides is
predicted to proceed via a β-branch acetate extension, as seen
with the jamaicamides, and most likely occurs in malyngamide
biosynthesis.3,12,21 A nonheme Fe(II), α-ketoglutarate-depend-
ent halogenase similar to the Jam halogenase is expected to
halogenate C-2 of acetate during β-branch formation. Following
dehydration, a decarboxylase similar to Jam ECH2 must
decarboxylate this pendant group in a regiospecific manner to
yield the vinyl chloride.3,12
Evolution, Taxonomy, and Metabolic Origin of the
Credneramides. Morphologically, the credneramide-produc-
ing cyanobacterial specimen from Papua New Guinea (PNG-
05/19/05-13; GenBank acc. no. 1452341) agreed well with the
current definition of either Lyngbya or Oscillatoria (Figure 2; for
morphological description, see Supporting Information).
Marine forms of Lyngbya and Oscillatoria typically share their
entire range of cellular types and are often misidentified.24,25
Phylogenetic inferences of the SSU (16S) rRNA gene from two
credneramide-producing specimens were used to determine the
taxonomic identity by inferring its evolutionary relationship to
relevant reference and type-strains. The credneramide-produc-
ing strain formed a clade with other benthic tropical marine
cyanobacteria with similar morphology, including the strains
PAL08-3.2 (GenBank acc. no. HM585025) from Palmyra atoll
and NAC8-50 (GenBank acc. no. GU724203) from the
Caribbean island of Curaca̧o. This group is evolutionarily
most closely related to the planktonic genus Trichodesmium
(reference/type-strains = Trichodesmium erythraeum IMS 101T;
p-distance 2.3%). The ecological and evolutionary distinction
suggests that the credneramide-producing strain, in fact,
represents a new taxon. Technically, either this new taxon
could be included in the genus Trichodesmium, which would
require a change in the definition of this planktonic genus to
also include benthic forms, or alternatively, this group needs to
be erected as a separate generic entity. More careful taxonomic
comparison between the two groups must be performed to
establish firmly the placement of this new taxon. Presently, this
strain is best defined as a cf. Trichodesmium sp. nov.
The predicted precursor of the credneramides, credneric acid
(3), was also isolated from a filamentous cyanobacterial
specimen (Oscillatoria sp., PAC-17-FEB-10-3; GenBank acc.
no. 1452343) obtained from the Pacific coast of Panama.
Phylogenetic comparison between the strain from Papua New
Guinea and the Panamanian strain revealed that these two
credneric acid-producing strains are unrelated and belong to
two different genera (Figure 2). Strain PNG-05/19/05-13 is
most closely related evolutionarily to the genus Trichodesmium,
whereas strain PAC-17-FEB-10-3 belongs to a clade of tropical
marine Oscillatoria. To determine if this secondary metabolite is
the result of a more ancient biosynthetic pathway, several
related specimens, including the strains NAC8-50, 3LOSC
(GenBank acc. no. EU244875), PAB-21 (EU253967), NAC8-
46 (GU724197), and NAC8-55 (GU724208), were screened
by ESI-LC-MS for a molecular weight corresponding to
credneric acid. The fact that this secondary metabolite was
not present in any other of these specimens suggests that its
biosynthetic pathway has not been inherited vertically, at least
within these groups of cyanobacteria.
Another possibility for this disjunct taxonomic distribution of
credneric acid in these cyanobacteria is suggested by the recent
isolation of credneric acid (3) from the epiphytic heterotrophic
bacterium Rhodopirellula baltica.22 Since this bacterium is
known to grow in association with other marine organisms,
there is the possibility that credneric acid isolated from our
cyanobacterial specimens is actually produced by R. baltica
living in association with the cyanobacteria. To determine
whether R. baltica was present in our collections and, therefore,
the likely producer of credneric acid, an attempt was made to
amplify the 16S rRNA gene sequence of R. baltica from the
Panamanian and Papua New Guinean strains using specifically
designed primers and to compare that data with the 16S rRNA
sequence for R. baltica (H. S. Lee, personal communication).
However, sequencing of several clones from libraries generated
using these specific primers resulted in gene sequences of
heterotrophic bacteria other than R. baltica. Thus, because the
biosynthetic machinery for production of the vinyl chloride
functional group has been carefully and quite thoroughly
described in other marine cyanobacteria,3,12 and the fact that
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another well-known marine cyanobacterial metabolite (malyn-
gic acid)26 was also isolated from the field collection of R.
baltica,22 we believe that these metabolites derive from
cyanobacterial metabolism. Their occurrence in the field-
collected R. baltica therefore may have resulted from small
filaments of Trichodesmium or Oscillatoria contaminating this
environmental sample.
Biological Activity and Ecological Significance of
Credneramides. Credneramides A (1) and B (2), and
credneric acid (3), were subjected to a suite of bioassays to
explore their activities. Although the parent extract possessed
sodium-channel blocking activity, the activity of 1 and 2 in this
assay was very modest. Their most potent activity was
inhibition of calcium oscillations in cerebrocortical mouse
neurons (1, IC50 4.0 μM; 2, IC50 3.9 μM). Compound 3 also
exhibited modest calcium oscillation inhibition (IC50 8.2 μM)
with a Hill slope of its concentration response curve consistent
with a 1:1 ligand−receptor binding (data not shown). In
contrast, the steep Hill slopes of the concentration curves for 1
and 2 suggest positive cooperativity (Figure 3). Given that the
credneric acid demonstrates a less potent response, and 1 and 2
confer somewhat more specific calcium inhibition, it is logical
that the PEA and isopentylamine moieties may be responsible
for the enhanced activity of each compound.21
The calcium oscillations observed in primary and mature
cerebrocortical neurons of mice are sensitive to AMPA receptor
modulation as well as to group I metabotropic glutamate
receptor (mgluR) agonism or antagonism.27 AMPA receptors
regulate calcium oscillation frequency, while mgluR regulates
frequency and amplitude as well as release of intracellular
calcium stores via phospholipase C (PLC). Thus, the
bioactivity of the credneramides in this assay could be due to
modulation of AMPA, mgluR, or PLC signaling or to TAAR1,
dopamine, and GABA receptor activity; the latter three are
known to be modulated by PEA.28−31 Unlike grenadamide A, a
mixture of 1 and 2 did not possess cannabinoid receptor
binding activity, and only marginal cytotoxic activity against the
beet armyworm Spodoptera exigua was reported for grenada-
mides B and C, which are structurally most similar to the
credneramides.23
Fatty acids with phenethylamine have been encountered
increasingly among cyanobacterial metabolites. PEA derivatives
have a well-recognized role in mammalian physiology as an
endogenous neurotransmitter that has been shown to bind
trace amine (TAAR), dopaminergic, and GABA receptors.28−31
By binding to these receptors, PEA derivatives modulate higher
cognitive function via a capacity to act as hallucinogens,
stimulants, and antidepressants.28,29 This class of compounds
has also been implicated in the pathogenesis of several
neurologic diseases including depression, attention deficit and
hyperactivity disorder (ADHD), and schizophrenia.28,29,32
Given the substantial evidence of neuromodulation by
phenethylamines, the neuromodulatory effects of credneramide
A (1) are reasonable.
The ecologic and physiologic role of reductively decarboxy-
lated fatty acid amides, particularly those containing PEA, in
lower life forms is poorly understood. While they may serve in
antipredatory or antifeedant roles, it is also possible that they
serve a role similar to that of neurotransmitters in higher life
forms, namely, to mediate intercellular signaling. Fatty acid
amides with functionalized head groups similar to PEA mimic
N-acyl homoserine lactones (AHL), which are quorum-sensing
molecules in diverse bacteria.33 At threshold concentrations,
AHLs bind “sensor peptides” that are transcriptional regulators
and activate the expression of genes of varying functions such as
those involved in antibiotic synthesis and motility.33
Malyngamide C and epi-malyngamide C are two other fatty
acid amides isolated from cyanobacteria with demonstrated
quorum sensing properties.34 Thus, it is possible that the
credneramides also have roles in intercellular communication
and quorum sensing.
■ CONCLUSIONS
Credneramides A (1) and B (2), neuromodulatory phenethyl-
amine and isopentylamine derivatives of a vinyl chloride-
containing fatty acid, were isolated from a Papua New Guinea
collection of cf. Trichodesmium sp. nov. The precursor fatty
acid, credneric acid (3), was also isolated from both the
aqueous and organic fractions of the parent fraction, in addition
to a phylogenically distinct Panamanian collection. The true
source of credneric acid production remains somewhat
uncertain. However, the constellation of findings, the wide-
spread and well-characterized vinyl chloride functionality in
other marine cyanobacterial metabolites, and the co-occurrence
of another well-known cyanobacterial metabolite in the report
from the heterotrophic bacterium R. baltica indicate that these
filamentous cyanobacteria are the likely biosynthetic source.
Credneric acid (3) appears to serve as a template for
biochemical elaboration and enhancement of bioactivity.
■ EXPERIMENTAL SECTION
General Experimental Procedures. IR and UV spectra were
obtained using a Nicolet IR-100 FT-IR and Beckman-Coulter DU800
spectrophotometer, respectively. NMR spectra were obtained using
Varian Unity 300 and 500 MHz spectrometers and a Bruker 600 MHz
spectrometer [CDCl3 (δH 7.26; δC 77.0) was used as an internal
standard]. High-resolution mass spectra were obtained using an
Agilent ESI-TOF mass spectrometer (TSRI, La Jolla, CA) and a
Thermo Finnigan MAT900XL spectrometer (UCSD, La Jolla, CA).
LC-ESI-MS profiling of extracts was performed with a Finnigan LCQ
Advantage Max using a LiChrospher 100 RP18 column (5 μm, 125 ×
4 mm) and elution gradients of CH3CN−MeOH (1:1) to 100%
CH3CN over 15 to 30 min. Flash chromatography was performed
using EM Science silica gel (230−400 mesh). VLC was performed
using TLC grade silica gel. TLC was performed using EM Science
precoated silica gel plates (Merck 60 F254). Extracts were processed
using a HPLC Waters 515 pump, Waters 996 photodiode array
detector, and Millenium software for acquisition and analysis of data.
Figure 3. Calcium oscillation inhibition in cerebrocortical mouse
neurons by credneramides A (1) (IC50 4.0 μM) and B (2) (IC50 3.8
μM).
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Organism Collection. The cf. Trichodesmium sp. nov. sample
(PNG-05/19/05-13) was collected in May 2005 by snorkel at a depth
of 1−2 m near the Credner Islands of Papua New Guinea (4ο14.105′ S
and 152ο25.605′ E). The Oscillatoria sp. sample (PAC-02/17/10-3)
was collected in February 2010 in shallow waters near Isla Canales de
Afuera of Panama (7ο41.723′ N and 81ο38.025′ W). Both specimens
were stored in 70% EtOH in a 1 L container at −20 οC until
extraction.
DNA Extraction, Amplification, and Sequencing. Cyanobac-
terial biomass (∼50 mg) was partly cleaned under an Olympus VMZ
dissecting microscope. Genomic DNA was extracted using the Wizard
Genomic DNA purification kit (Promega) following the manufac-
turer’s specifications. DNA concentration and purity were measured
on a DU-800 spectrophotometer (Beckman Coulter). The 16S rRNA
genes were PCR-amplified from isolated DNA using the modified
lineage-specific primers, OT106F 5′-GGACGGGTGAGTAACGCGT-
GA-3′ and OT1445R 5′-AGTAATGACTTCGGGCGTG-3′. The PCR
reaction volumes were 25 μL containing 0.5 μL (∼50 ng) of DNA, 2.5
μL of 10× PfuUltra IV reaction buffer, 0.5 μL (25 mM) of dNTP mix,
0.5 μL of each primer (10 μM), 0.5 μL of PfuUltra IV fusion HS DNA
polymerase, and 20.5 μL of dH2O. The PCR reactions were performed
in an Eppendorf Mastercycler gradient as follows: initial denaturation
for 2 min at 95 °C, 25 cycles of amplification, followed by 20 s at 95
°C, 20 s at 55 °C, and 1.5 min at 72 °C, and final elongation for 3 min
at 72 °C. PCR products were purified using a MinElute PCR
purification kit (Qiagen) before subcloning using the Zero Blunt
TOPO PCR cloning kit (Invitrogen) following the manufacturer’s
specifications. Plasmid DNA was isolated using the QIAprep Spin
Miniprep kit (Qiagen) and sequenced with M13 primers. The 16S
rRNA gene sequences are available in the DDBJ/EMBL/GenBank
databases under acc. nos. 1452341 and 1452343.
Phylogenetic Inference. The 16S rRNA gene sequence of PAC-
17-FEB-10-2 was aligned with evolutionary informative cyanobacteria
using the L-INS-I algorithm in MAFFT 6.71735 and refined using the
SSU secondary structures model for Escherichia coli J0169536 without
data exclusion. The best-fitting nucleotide substitution model
optimized by maximum likelihood was selected using corrected
Akaike/Bayesian Information Criterion (AICC/BIC) in jModeltest
0.1.1.37 The evolutionary histories of the cyanobacterial genes were
inferred using maximum likelihood (ML) and Bayesian inference
algorithms. The ML inference was performed using GARLI 1.038 for
the GTR+I+G model assuming a heterogeneous substitution rate and
gamma substitution of variable sites (proportion of invariable sites
(pINV) = 0.494, shape parameter (α) = 0.485, number of rate
categories = 4) with 1000 bootstrap-replicates. Bayesian inference was
conducted using MrBayes 3.139 with four Metropolis-coupled MCMC
chains (one cold and three heated) run for 3 000 000 generations. The
first 25% were discarded as burn-in, and the following data set were
sampled with a frequency of every 100 generations. The MCMC
convergence was detected by AWTY.40
Extraction and Isolation. The cf. Trichodesmium sp. nov.
collection was extracted 10 times with heat using CH2Cl2−MeOH
(2:1) to yield a crude organic extract of mass 12.2 g. Approximately 3 g
of this crude extract was processed further on silica gel using vacuum-
liquid chromatography with a 100% hexanes−EtOAc−MeOH gradient
to generate nine subfractions, A−I. Fraction E eluted with 60/40
EtOAc−hexanes and harbored the most potent sodium channel
blocking activity in neuro-2A neuroblastoma cells. Fraction E (240.5
mg) was filtered subsequently using a Waters RP C18 SPE cartridge
and processed further using reversed-phase HPLC (Phenomenex RP
C18 Jupiter 250 × 10 mm, 10 μm; 50:50 CH3CN−H2O to 100%
CH3CN in 30 min; 100% CH3CN 30−45 min) to yield 7.0 mg of a
mixture of credneramides A (1) and B (2) and 9.6 mg of credneric
acid (3). The mixture was processed further (C18 Kromasil 250 × 4.6
mm, 5 μm; 70:30 CH3CN−H2O isocratic) to yield 1.4 mg of pure
credneramide A (1) and 0.8 mg of credneramide B (2). The remaining
aqueous layers and the EtOH used for preservation of the alga were
combined, and the volatiles were removed under vacuum. The
residues were resuspended in EtOH, and the insolubles were removed
by filtration. Filtration of this material over a pad of water-treated silica
gel with EtOH was followed by silica gel solid-phase extraction (SPE)
chromatography, sequentially eluting with 1:1 CH2Cl2−EtOAc,
EtOAc, 1:9 MeOH−CH2Cl2, and 3:7 MeOH−CH2Cl2. Four fractions
(4 mg, 422 mg, 1.08 g, and 1.09 g, respectively) were obtained. On the
basis of TLC characteristics, the third SPE fraction was subjected to
flash column chromatography with silica gel with a gradient mixture of
MeOH and CH2Cl2 as the mobile phase to obtain several fractions.
One of the fractions contained a partially purified compound (7 mg),
and it was further purified by semipreparative reversed-phase HPLC
(250 × 10.00 mm, Synergi 4 μm Hydro-RP 80A column, CH3CN−
H2O gradient) to obtain an additional 4 mg of credneric acid (3) as a
colorless oil.
The Oscillatoria sp. collection was extracted five times using
CH2Cl2−MeOH (2:1) to yield a crude organic extract of mass 90.6
mg. This crude extract (82.9 mg) was processed further on silica gel
using vacuum-liquid chromatography, as described above, to generate
nine subfractions, A−I. Fraction E eluted with 60:40 EtOAc−hexanes
(5.8 mg) and was purified further using preparative TLC [hexanes−
EtOAc (1:1) + 0.1% AcOH] to yield 1.9 mg of credneric acid (3).
Credneramide A (1): clear oil; [α]D +14 (c 0.1, MeOH); UV
(MeOH) λmax (log ε) 206 (4.21), 257 (2.36) nm; IR (neat) νmax 3289,
3068, 3028, 2959, 2930, 2869, 1644, 1551, 1453, 970, 746 cm−1; 1H
NMR (CDCl3, 500 MHz) and
13C NMR (CDCl3, 75 MHz) data, see
Table 1; HRESI(+)MS m/z 320.1779 [M + H]+ (calcd for
C19H27ClNO, 320.1781).
Credneramide B (2): clear oil; [α]D −2.5 (c 0.1, MeOH); UV
(MeOH) λmax (log ε) 203 (3.98) nm; IR (neat) νmax 3305, 2958, 2926,
2857, 1709, 1644, 1554, 1461, 1376, 1172, 1071, 605 cm−1; 1H NMR
(CDCl3, 500 MHz) and
13C NMR (CDCl3, 75 MHz) data, see Table
1; HRESI(+)MS m/z 286.1963 [M + H]+ (calcd for C16H29ClNO,
286.1938).
Credneric acid (3): clear oil; [α]D +7.4 (c 0.2, MeOH); UV
(MeOH) λmax (log ε) 203 (3.77), 269 (2.81) nm; IR (neat) νmax 3428
(br), 2965, 2930, 2873, 1711, 1632, 1431, 1410, 1284, 1252, 1212,
1158, 968, 795 cm−1; 1H NMR (CDCl3, 500 MHz) δ 5.79 (1H, s, H-
11), 5.48 (1H, dt, J = 15.4, 6.2, H-4), 5.42 (1H, dt, J = 15.4, 6.4, H-5),
2.73 (2H, d, J = 6.2, H2-6), 2.44 (2H, t, J = 7.4, H2-2), 2.35 (2H, dt, J =
7.0, 6.4, H2-3), 2.16 (2H, t, J = 7.7, H2-8), 1.44 (2H, h, J = 7.5, H2-9),
0.92 (3H, t, J = 7.3, H3-10);
13C NMR (CDCl3, 75 MHz) δ 178.9 (C,
C-1), 141.4 (C, C-7), 130.5 (CH, C-4), 128.1 (CH, C-5), 113.1 (CH,
C-11), 37.9 (CH2, C-6), 33.7 (CH2, C-2), 32.2 (CH2, C-8), 27.4
(CH2, C-3), 20.2 (CH2, C-9), 13.9 (CH3, C-10); HREIMS m/z
217.0995 [M + H]+ (calcd for C11H18O2Cl, 217.0990).
Biological Testing. A mixture containing 1 and 2 was screened
for biological activity in an H460 cytotoxicity assay, neuro-2A sodium
channel activation and blocking assays, malaria, Chagas’ disease, and
leishmania antiparasitic assays, and a cannabinoid receptor binding
assay. Compounds 1−3 were also submitted for testing in a
neocortical neuron calcium oscillation assay. See reported references
for the calcium oscillation assay,27 the H460 cytotoxicity assay,41 the
neuro-2A assays,42 and the antiparasitic assays used.43−46
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